Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why angiogenesis inhibition? Commentary.

T Boehm-Viswanathan1

  • 1Department of Surgical Research, Children's Hospital, Harvard Medical School, Ender's Research Building, Boston, MA 02115, USA.

International Journal of Molecular Medicine
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is angiogenesis inhibition the Holy Grail of cancer therapy?

Current opinion in oncologyยท2000
See all related articles

Targeting tumor blood vessel formation, or antiangiogenesis, offers a promising strategy to inhibit cancer growth. This approach complements traditional tumor cell-focused therapies, addressing limitations in current cancer treatment paradigms.

Area of Science:

  • Oncology
  • Cancer Biology
  • Vascular Biology

Background:

  • Traditional cancer research has primarily focused on tumor cells.
  • A 1971 hypothesis proposed that inhibiting tumor-induced blood vessel formation (angiogenesis) could halt tumor growth.
  • Despite current interest, antiangiogenesis therapies have yet to yield effective clinical compounds.

Purpose of the Study:

  • To discuss the limitations of established anti-tumor therapy paradigms.
  • To highlight the advantages of the antiangiogenesis paradigm in cancer treatment.
  • To advocate for increased scientific focus on angiogenesis inhibition as a valid anti-cancer strategy.

Main Methods:

  • This commentary critically evaluates existing anti-cancer strategies.
  • It contrasts the established tumor-centric approach with the antiangiogenesis paradigm.

Related Experiment Videos

  • It discusses the potential and challenges of targeting tumor vasculature.

    • Main Results:

    • Established anti-tumor therapies face limitations in effectively eradicating all cancer.
    • The antiangiogenesis paradigm presents a complementary strategy by targeting tumor support systems.
    • Further research is needed to overcome challenges and develop effective antiangiogenesis compounds.

    Conclusions:

    • Antiangiogenesis is a valid and crucial concept for inhibiting tumor growth.
    • Overcoming the limitations of current cancer treatments requires exploring novel therapeutic avenues.
    • Increased momentum in antiangiogenesis research is essential for discovering effective cancer therapies.